A detailed history of Danske Bank A/S transactions in Haemonetics Corp stock. As of the latest transaction made, Danske Bank A/S holds 111 shares of HAE stock, worth $8,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111
Holding current value
$8,157
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 19, 2025

BUY
$47.67 - $78.17 $645,547 - $1.06 Million
13,542 Added 12200.0%
13,653 $665,000
Q3 2025

Nov 13, 2025

BUY
$47.67 - $78.17 $5,291 - $8,676
111 New
111 $5.41 Million
Q2 2025

Dec 18, 2025

BUY
$56.04 - $74.77 $664,242 - $886,248
11,853 Added 169.33%
18,853 $1.41 Million
Q1 2025

Dec 18, 2025

SELL
$59.34 - $80.05 $394,789 - $532,572
-6,653 Reduced 48.73%
7,000 $444,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Danske Bank A/S Portfolio

Follow Danske Bank A/S and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

News

Stay updated on Danske Bank A/S with notifications on news.